Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism
NCT02514070Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Oct 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid, docosahexaenoic acid in hypertriglyceridemia, sponsored by National Heart, Lung, and Blood Institute. Started Oct 2015; status: completed.
02
Drugs
eicosapentaenoic aciddocosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02514070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514070.